Healthcare -
Biotechnology - NASDAQ - US
$ 9.25
-0.213 %
$ 646 M
Market Cap
-0.91
P/E
PHAT - OTHER LONG-TERM ASSETS
Other Long-term Assets PHAT - Phathom Pharmaceuticals, Inc.
16.1 M
LAST VALUE
633.69%
2 YEAR CAGR
145.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR